Samsara Vision, Inc. operates as a medical device business engaged in the research, development, manufacture, and marketing of implantable ophthalmic devices and technologies. The company develops, manufactures, and markets proprietary implantable ophthalmic devices for individuals with untreatable retinal disorders, with its primary product being the Implantable Miniature Telescope (IMT) by Dr. Isaac Lipshitz, an FDA-approved device for improving vision in patients with advanced, irreversible age-related macular degeneration. The company provides support services for patients, including access care management and assistance with Medicare reimbursement processes for both patients and healthcare providers. It collaborates with healthcare professionals such as retina specialists, corneal surgeons, occupational therapists, and low vision specialists to determine patient eligibility and support the patient journey. The company also conducts ongoing research and development in micro-optical design and manufacturing for ophthalmic applications. Samsara Vision serves health care providers, including physicians, licensed practitioners, retina specialists, corneal surgeons, occupational therapists, low vision specialists, and hospital surgical facilities. The company was founded in 2015 and is based in Far Hills, New Jersey.